• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用雌激素替代疗法的绝经后妇女的钙补充与骨矿物质密度

Calcium supplementation and bone mineral density in postmenopausal women using estrogen replacement therapy.

作者信息

Haines C J, Chung T K, Leung P C, Hsu S Y, Leung D H

机构信息

Department of Obstetrics and Gynaecology, Chinese University of Hong Kong, New Territories.

出版信息

Bone. 1995 May;16(5):529-31. doi: 10.1016/8756-3282(95)00084-q.

DOI:10.1016/8756-3282(95)00084-q
PMID:7654468
Abstract

Both estrogen and calcium have been shown to be of benefit in reducing the incidence of osteoporosis in postmenopausal women. It has been suggested that estrogen promotes the intestinal absorption of calcium, and this effect may especially benefit postmenopausal women with a low dietary intake of calcium. The purpose of this study was to examine the effect of calcium supplementation on the bone mineral density (BMD) of postmenopausal women using estrogen replacement therapy. BMD measurements were made over 12 months in two groups of postmenopausal women, one having treatment with estrogen alone, and the second having estrogen and 1000 mg of supplemental calcium each day. There was no significant reduction in BMD between the two groups over the 12-month study period. Those in the group having supplemental calcium had a significant increase in BMD at the femoral neck (p = 0.023), but not in other areas of the femur nor in the lumbar spine. The results of this study suggest that the addition of supplemental calcium may improve the bone mass of postmenopausal women using estrogen who have a low dietary calcium intake. This benefit appears to be more pronounced in corticocancellous than in trabecular bone, and may therefore have a greater effect on the femoral neck than the lumbar spine.

摘要

雌激素和钙都已被证明有助于降低绝经后女性骨质疏松症的发病率。有人认为,雌激素可促进肠道对钙的吸收,这种作用可能对钙摄入量低的绝经后女性尤其有益。本研究的目的是研究补充钙对接受雌激素替代疗法的绝经后女性骨密度(BMD)的影响。对两组绝经后女性进行了为期12个月的骨密度测量,一组仅接受雌激素治疗,另一组每天接受雌激素和1000毫克补充钙治疗。在12个月的研究期内,两组之间的骨密度没有显著降低。补充钙的组在股骨颈处的骨密度显著增加(p = 0.023),但在股骨的其他部位和腰椎处没有增加。本研究结果表明,补充钙可能会改善钙摄入量低且正在使用雌激素的绝经后女性的骨量。这种益处似乎在皮质骨松质中比在小梁骨中更明显,因此对股骨颈的影响可能比对腰椎的影响更大。

相似文献

1
Calcium supplementation and bone mineral density in postmenopausal women using estrogen replacement therapy.使用雌激素替代疗法的绝经后妇女的钙补充与骨矿物质密度
Bone. 1995 May;16(5):529-31. doi: 10.1016/8756-3282(95)00084-q.
2
Prevention of postmenopausal bone loss by low and conventional doses of calcitriol or conjugated equine estrogen.低剂量和常规剂量骨化三醇或结合马雌激素预防绝经后骨质流失。
Maturitas. 2000 Feb 15;34(2):179-84. doi: 10.1016/s0378-5122(99)00091-2.
3
Correlates of bone mineral density in the postmenopausal estrogen/progestin interventions trial.绝经后雌激素/孕激素干预试验中骨矿物质密度的相关因素
J Bone Miner Res. 1994 Sep;9(9):1467-76. doi: 10.1002/jbmr.5650090920.
4
Bone mineral density in postmenopausal Chinese women treated with calcium fortification in soymilk and cow's milk.绝经后中国女性在强化豆浆和牛奶中钙补充剂治疗后的骨密度。
Osteoporos Int. 2012 May;23(5):1563-70. doi: 10.1007/s00198-012-1895-z. Epub 2012 Jan 27.
5
Site-dependent bone mineral density response to oral pamidronate and calcium in postmenopausal osteoporosis: a preliminary report.绝经后骨质疏松症患者口服帕米膦酸盐和钙剂后骨矿物质密度的部位依赖性反应:初步报告
Clin Rheumatol. 1997 Jun;16(4):346-52. doi: 10.1007/BF02242450.
6
Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?维生素D能否增强接受雌激素治疗的骨质疏松症女性股骨颈骨密度的增加?
Osteoporos Int. 1998;8(1):32-8. doi: 10.1007/s001980050045.
7
[Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].[雌激素治疗对绝经后骨质减少女性骨量的影响]
Medicina (B Aires). 1995;55(5 Pt 1):408-14.
8
Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.雌激素与骨化三醇联合治疗预防年龄相关性骨质流失
J Clin Endocrinol Metab. 2001 Aug;86(8):3618-28. doi: 10.1210/jcem.86.8.7703.
9
Not all postmenopausal women on chronic steroid and estrogen treatment are osteoporotic: predictors of bone mineral density.
Calcif Tissue Int. 1997 Nov;61(5):377-81. doi: 10.1007/s002239900351.
10
Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study.维生素D与激素替代疗法:在预防绝经后早期女性骨质流失方面,并无超出单独使用激素替代疗法的额外益处。一项为期2.5年的随机安慰剂对照研究。
Osteoporos Int. 1997;7(2):126-32. doi: 10.1007/BF01623687.

引用本文的文献

1
Repair calvarial defect of osteoporotic rats by berberine functionalized porous calcium phosphate scaffold.黄连素功能化多孔磷酸钙支架修复骨质疏松大鼠颅骨缺损
Regen Biomater. 2021 Jun 1;8(3):rbab022. doi: 10.1093/rb/rbab022. eCollection 2021 Jun.
2
Prioritization of candidate metabolites for postmenopausal osteoporosis using multi-omics composite network.使用多组学复合网络对绝经后骨质疏松症的候选代谢物进行优先级排序。
Exp Ther Med. 2019 Apr;17(4):3155-3161. doi: 10.3892/etm.2019.7310. Epub 2019 Feb 26.
3
Protective effects of resveratrol on osteoporosis via activation of the SIRT1-NF-κB signaling pathway in rats.
白藜芦醇通过激活大鼠SIRT1-NF-κB信号通路对骨质疏松症的保护作用
Exp Ther Med. 2017 Nov;14(5):5032-5038. doi: 10.3892/etm.2017.5147. Epub 2017 Sep 20.
4
The risks and benefits of calcium supplementation.钙补充的风险和益处。
Endocrinol Metab (Seoul). 2015 Mar 27;30(1):27-34. doi: 10.3803/EnM.2015.30.1.27.